Life Science Tools Market, By Product (Consumables, Instruments, Services), By Technology (Genomics, Proteomics, Cell Biology, Stem Cell Research, Immunology), By Application (Drug Discovery and Development, Clinical Diagnostics, Genomic and Proteomic Res

Life Science Tools Market, By Product (Consumables, Instruments, Services), By Technology (Genomics, Proteomics, Cell Biology, Stem Cell Research, Immunology), By Application (Drug Discovery and Development, Clinical Diagnostics, Genomic and Proteomic Research, Cell Biology Research, Others), By End User (Academic and Research Institutions, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Contract Research Organizations, Government and Regulatory Agencies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)


With an increasing focus on developing new therapies and diagnostics, the life science tools market is witnessing significant growth. Various tools and technologies such as cell biology, genetic tools, biomarker analysis, and microscopy are being employed to understand disease mechanisms at a molecular level. Growing research activities in biotechnology and pharmaceutical companies as well as academic research organizations are propelling the demand for high-quality, innovative life science tools. Furthermore, advancements in areas like personalized medicine, drug discovery, and regenerative medicine are bolstering investments in life science research, thereby driving the market growth.

Market Dynamics:

The life science tools market is driven by factors such as increasing R&D expenditure in the pharmaceutical and biotechnology industries, rising government funding for life science research, and growing focus on precision medicine. However, high costs associated with advanced life science tools is a major factor restraining the market growth. On the flip side, emerging economies provide significant growth opportunities for players in this market. Emerging markets are witnessing increasing investments in healthcare research which bodes well for the adoption of advanced life science tools. Growing application of multi-omics technologies also presents an opportunity to further enhance research capabilities.

Key Features of the Study:
  • This report provides an in-depth analysis of the global life science tools market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global life science tools market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Agilent Technologies, Inc., BD, F. Hoffmann-La Roche Ltd, Bruker, Danaher, GE Healthcare, Hitachi, Ltd., Illumina, Inc., Merck KGaA, Oxford Instruments, QIAGEN, Shimadzu Corporation, Thermo Fisher Scientific Inc., ZEISS Group, Bio-Rad Laboratories, and Hamilton Company.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global life science tools market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global life science tools market.
Detailed Segmentation-
  • Product:
  • Consumables
  • Instruments
  • Others
  • Technology:
  • Genomics
  • Proteomics
  • Cell Biology
  • Stem Cell Research
  • Immunology
  • Application:
  • Drug Discovery and Development
  • Clinical Diagnostics
  • Genomic and Proteomic Research
  • Cell Biology Research
  • Others
  • End User:
  • Academic and Research Institutions
  • Biotechnology and Pharmaceutical Companies
  • Hospitals and Diagnostic Laboratories
  • Contract Research Organizations (CROs)
  • Government and Regulatory Agencies
  • Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
  • Company Profiles:
  • Agilent Technologies, Inc.
  • BD
  • Hoffmann-La Roche Ltd
  • Bruker
  • Danaher
  • GE Healthcare
  • Hitachi, Ltd.
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Instruments
  • QIAGEN
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • ZEISS Group
  • Bio-Rad Laboratories
  • Hamilton Company


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Vaccine Type
Market Snapshot, By Disease Type
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Pipeline Analysis
Epidemiology
Pricing and Brand Analysis
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter’s Analysis
4. Global Preventive Vaccines Market- Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the market
5. Global Preventive Vaccines Market, By Vaccine Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Live/Attenuated Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Inactivated Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Subunit Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Toxoid Vaccines
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
6. Global Preventive Vaccines Market, By Disease Type, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Pneumococcal
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Poliovirus
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Hepatitis
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Influenza
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Measles
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Rubella
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
7. Global Preventive Vaccines Market, By Distribution Channel, 2019 – 2031, (USD Bn)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Public
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
Private
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD Bn)
8. Global Preventive Vaccines Market, By Region, 2019 – 2031, (USD Bn)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Regions, 2019–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD Bn)
North Africa
Central Africa
South Africa
9. Competitive Landscape
Company Profiles
Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Pfizer Inc.
Merck & Co. Inc.
GSK plc.
Takeda Pharmaceutical Company Limited
AstraZeneca
Daiichi Sankyo Co. Ltd.
Emergent BioSolutions Inc.
Novavax Inc.
Zydus Group
Moderna, Inc.
Sinopharm Group Co. Ltd.
Valneva SE
Serum Institute of India Pvt. Ltd.
Johnson & Johnson Services, Inc.
Bharat Biotech
Regeneron Pharmaceuticals Inc.
10. Analyst View
Wheel of Fortune
Analyst View
Coherent Opportunity Map
11. References and Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 36 market data tables and 32 figures on Preventive Vaccines Market” -Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings